The Oncology Institute, Inc. (TOI)Healthcare | Medical Care Facilities | Cerritos, United States | NasdaqCM
3.49 USD
-0.03
(-0.852%) ⇩
(April 21, 2026, 12:08 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 11:29 p.m. EDT
The Oncology Institute is currently sitting at a critical inflection point where a deep short-term bottom appears imminent. Despite deteriorating fundamentals (negative EPS, negative EBITDA, high debt load), the combination of successful Q4 earnings, a pending dividend announcement (yielding 20x+ based on current lows), and aggressive options positioning suggests a 'stop-loss squeeze' or sentiment reversal is the primary near-term catalyst. However, this is a 'buy the dip' scenario that relies heavily on the continued success of the multi-year turnaround strategy; without profitable growth, the debt load eventually demands remediation. The current setup favors a short-term speculative bounce but does not support a long-term accumulation of the shares. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.131548 |
| AutoETS | 0.150024 |
| AutoARIMA | 0.155148 |
| AutoTheta | 0.206912 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.13 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.440 |
| Excess Kurtosis | -0.81 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 5.441 |
| Market Cap | 344,948,608 |
| Forward P/E | -21.81 |
| Beta | 0.20 |
| Profit Margins | -12.06% |
| Website | https://theoncologyinstitute.com |
As of April 18, 2026, 11:29 p.m. EDT: Options flow shows a massive long skew in Call volume, particularly at out-of-the-money strikes (e.g., $7.00 calls posted a +97.7% volume change with high OI), significantly outweighing put activity. While ATM IV on near-term calls is historically low (2.03%), the 'New Flow' note on $1.00 calls combined with heavy long-dated call positioning suggests speculators are pricing in a substantial upside move, essentially betting on an immediate trend reversal following the recent 20% drop. Put activity is minimal and concentrated deeply in-the-money, indicating a lack of organized short-term hedging against further immediate declines.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.29889297 |
| Address1 | 18,000 Studebaker Road |
| Address2 | Suite 800 |
| All Time High | 12.66 |
| All Time Low | 0.125 |
| Ask | 4.45 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 1,490,050 |
| Average Daily Volume3 Month | 1,931,432 |
| Average Volume | 1,931,432 |
| Average Volume10Days | 1,490,050 |
| Beta | 0.2 |
| Bid | 2.66 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | -0.159 |
| City | Cerritos |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.49 |
| Current Ratio | 1.589 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.699 |
| Day Low | 3.46 |
| Display Name | The Oncology Institute |
| Earnings Call Timestamp End | 1,773,349,200 |
| Earnings Call Timestamp Start | 1,773,349,200 |
| Earnings Timestamp | 1,773,345,600 |
| Earnings Timestamp End | 1,778,529,600 |
| Earnings Timestamp Start | 1,778,529,600 |
| Ebitda | -29,139,000 |
| Ebitda Margins | -0.05796 |
| Enterprise To Ebitda | -14.348 |
| Enterprise To Revenue | 0.832 |
| Enterprise Value | 418,099,776 |
| Eps Forward | -0.16 |
| Eps Trailing Twelve Months | -0.54 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.9805 |
| Fifty Day Average Change | 0.5095 |
| Fifty Day Average Change Percent | 0.17094448 |
| Fifty Two Week Change Percent | 29.889297 |
| Fifty Two Week High | 4.88 |
| Fifty Two Week High Change | -1.3900001 |
| Fifty Two Week High Change Percent | -0.28483608 |
| Fifty Two Week Low | 2.015 |
| Fifty Two Week Low Change | 1.4749999 |
| Fifty Two Week Low Change Percent | 0.7320098 |
| Fifty Two Week Range | 2.015 - 4.88 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,591,277,400,000 |
| Float Shares | 64,830,571 |
| Forward Eps | -0.16 |
| Forward P E | -21.8125 |
| Free Cashflow | -11,004,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 641 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.15204 |
| Gross Profits | 76,435,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.20138 |
| Held Percent Institutions | 0.45016 |
| Implied Shares Outstanding | 98,839,144 |
| Industry | Medical Care Facilities |
| Industry Disp | Medical Care Facilities |
| Industry Key | medical-care-facilities |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. |
| Long Name | The Oncology Institute, Inc. |
| Market | us_market |
| Market Cap | 344,948,608 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_661363343 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -50,305,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 347,913,786 |
| Number Of Analyst Opinions | 4 |
| Open | 3.57 |
| Operating Cashflow | -24,587,000 |
| Operating Margins | -0.048660003 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 562 735 3226 |
| Previous Close | 3.52 |
| Price Hint | 4 |
| Price To Book | -21.949686 |
| Price To Sales Trailing12 Months | 0.6861522 |
| Profit Margins | -0.12055001 |
| Quick Ratio | 1.309 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | -0.029999971 |
| Regular Market Change Percent | -0.8522719 |
| Regular Market Day High | 3.699 |
| Regular Market Day Low | 3.46 |
| Regular Market Day Range | 3.46 - 3.699 |
| Regular Market Open | 3.57 |
| Regular Market Previous Close | 3.52 |
| Regular Market Price | 3.49 |
| Regular Market Time | 1,776,787,682 |
| Regular Market Volume | 1,432,159 |
| Return On Assets | -0.13369 |
| Revenue Growth | 0.416 |
| Revenue Per Share | 5.441 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 98,839,144 |
| Shares Percent Shares Out | 0.083900005 |
| Shares Short | 8,297,259 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 9,083,959 |
| Short Name | The Oncology Institute, Inc. |
| Short Percent Of Float | 0.1012 |
| Short Ratio | 3.36 |
| Source Interval | 15 |
| State | CA |
| Symbol | TOI |
| Target High Price | 8.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 7.0 |
| Target Median Price | 7.5 |
| Total Cash | 33,565,000 |
| Total Cash Per Share | 0.34 |
| Total Debt | 103,751,000 |
| Total Revenue | 502,728,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.54 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.408625 |
| Two Hundred Day Average Change | 0.08137512 |
| Two Hundred Day Average Change Percent | 0.0238733 |
| Type Disp | Equity |
| Volume | 1,432,159 |
| Website | https://theoncologyinstitute.com |
| Zip | 90,703 |